For many, the Straits Times Index (SGX: ^STI) represents businesses with strong market positions and fortress balance sheets.But take a step outside the circle, and you will find that there are cash-rich companies which are more than capable of sustaining a dividend.How do you go about searching for suitable candidates? Well, Stephen R. Covey, the author of 7 Habits of Highly Effective People, once said you should “begin with the end in mind.” For income investors, that end is a steady stream of dividends.B ...

Shares of Singapore Telecommunications slid more than 2% on Monday after a technical failure at its unit Optus, Australia's No. 2 telecom carrier, disrupted emergency call services for 13 hours last week and has since been linked to four deaths. ...

I last wrote about Axalta Coating Systems Ltd. (NYSE: AXTA ) back in Feburary this year. Since than the company has reported two quarterly results, frankly the results were not as good as I had expected. But theI am a value focused investor, conducting fundamental research on sectors like but not limited to chemicals, homebuilders, building materials, industrials and metals & mining. I prefer to invest in stocks which are cheaply available and have a catalyst in the near future. My investment horizon ranges ...

Core Insights - Axalta Coating Systems Ltd. (NYSE: AXTA) reported quarterly results that were below expectations since the last analysis in February [1] Company Performance - The recent quarterly results of Axalta were not as strong as anticipated, indicating potential challenges in performance [1] Investment Focus - The company is viewed through a value-focused investment lens, emphasizing fundamental research in sectors such as chemicals, homebuilders, building materials, industrials, and metals & mining [1] - The investment strategy prioritizes stocks that are undervalued and have near-term catalysts, with an investment horizon ranging from one quarter to two years [1]

Bendigo & Adelaide Bank Ltd (Since Covid lows, the ASX: BEN ) share price has been a mainstay for some ASX investors. Is now the time to load up on BEN shares? Let’s take a look at one way to value bank shares.Bank shares like Bank of Queensland Limited, Bendigo & Adelaide Bank Ltd (ASX: BEN) and Westpac Banking Corp (ASX: WBC) are very popular in Australia because they tend to have a stable dividend history, and often pay franking credits.In this article, we’ll explain the basics of investing in ASX bank s ...

Group 1 - Devon Energy is a major player in the US shale oil industry, focusing on shale fracking and operating in five key US shale basins [1] - The company is recognized for its value investment approach, aiming for high returns over a 3-8 year horizon [1] - There is an ongoing discussion about the future of shale oil, including questions about when peak shale will be reached [1] Group 2 - The article reflects a personal investment perspective, indicating a beneficial long position in Devon Energy shares [2] - The author emphasizes that the article expresses personal opinions and is not influenced by any business relationships with mentioned companies [2]

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].

Core Viewpoint - The Phase III clinical trial results of Fazamorexant, an innovative anti-insomnia drug developed by Yangtze River Pharmaceutical Group, were unveiled at the World Sleep Congress 2025, marking a significant milestone in the global development of treatments for sleep disorders [1][2]. Group 1: Clinical Trial Details - The Phase III clinical trial was a multi-center, randomized, double-blind, and placebo-controlled study involving 1,034 adult patients with insomnia, aimed at evaluating the efficacy and safety of Fazamorexant [5]. - Fazamorexant, as a dual orexin receptor antagonist (DORA), demonstrated rapid efficacy and a favorable safety profile in adult patients with insomnia [5][6]. Group 2: Performance Indicators - Fazamorexant showed exceptional performance in key sleep indicators, including improved sleep efficiency, shortened time to fall asleep, and decreased nighttime awakenings, significantly outperforming publicly available clinical data of other DORAs [6]. - The drug exhibited a favorable safety and tolerability profile, with no observed rebound insomnia or withdrawal symptoms after discontinuation [6]. Group 3: Expert Recognition and Future Prospects - The drug's fast-acting and short-half-life characteristics were highlighted, suggesting it meets the treatment needs of patients with difficulty falling asleep while maintaining daytime activities [8]. - Following the conference, interest in Fazamorexant was expressed by Professor Emmanuel Mignot from Stanford University, indicating potential for further collaboration in trials [9]. - Yangtze River Pharmaceutical has submitted a new drug application (NDA) for Fazamorexant to the National Medical Products Administration (NMPA), aiming for accelerated review and registration to provide innovative treatment options for insomnia patients globally [11].

Core Viewpoint - Quantum Computing Inc. has successfully entered into securities purchase agreements for an oversubscribed private placement, raising $500 million to support its growth initiatives and commercialization efforts [1][3]. Group 1: Offering Details - The private placement involves the sale of 26,867,276 shares of common stock, priced according to Nasdaq rules, and is expected to close around September 24, 2025 [1]. - The offering has attracted participation from large existing shareholders and a notable first-time investment from a global alternative asset manager [2][7]. - The total gross capital raised by the company since November 2024 will reach approximately $900 million following this offering [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to accelerate commercialization efforts, pursue strategic acquisitions, expand sales and engineering personnel, and for general corporate purposes [2][3]. - The company aims to strengthen its financial position and execute its multi-year growth plan with the funds raised [3]. Group 3: Company Overview - Quantum Computing Inc. specializes in integrated photonics and quantum optics technology, providing affordable quantum machines and photonic chip production services [5]. - The company's products are designed to operate at room temperature and low power, targeting high-performance computing, artificial intelligence, and cybersecurity applications [5].

Core Insights - The article emphasizes the focus on growth and momentum stocks that are reasonably priced and expected to outperform the market in the long term [1] - It highlights a significant investment opportunity, noting that the S&P 500 increased by 367% and the Nasdaq by 685% from 2009 to 2019, following a recommendation to buy at the financial crisis's bottom in March 2009 [1] Investment Strategy - The investment strategy involves long-term investment in quality stocks, with the use of options to enhance returns [1] - The goal is to assist investors in making money through investments in high-quality growth stocks [1]